We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
176
Guggenheim Capital
Illinois
– -$2.06M -6,495 Closed
OR
177
Olympiad Research
Connecticut
– -$2M -6,305 Closed
BG
178
Bellevue Group
Switzerland
– -$1.93M -6,100 Closed
SEI Investments
179
SEI Investments
Pennsylvania
– -$1.93M -6,097 Closed
YCM
180
Yakira Capital Management
Connecticut
– -$1.89M -5,981 Closed
Zurich Cantonal Bank
181
Zurich Cantonal Bank
Switzerland
– -$1.83M -5,770 Closed
NSEDCP
182
NJ State Employees Deferred Compensation Plan
New Jersey
– -$1.74M -5,500 Closed
ECM
183
ExodusPoint Capital Management
New York
– -$1.72M -5,443 Closed
MCM
184
Moore Capital Management
New York
– -$1.58M -5,000 Closed
CT
185
ClearAlpha Technologies
Connecticut
– -$1.5M -4,728 Closed
Simplex Trading
186
Simplex Trading
Illinois
– -$1.45M -4,574 Closed
DTL
187
Dynamic Technology Lab
Singapore
– -$1.43M -4,528 Closed
X
188
Xponance
Pennsylvania
– -$1.4M -4,432 Closed
CUAMC
189
China Universal Asset Management Company
China
– -$1.38M -4,363 Closed
Victory Capital Management
190
Victory Capital Management
Texas
– -$1.37M -4,338 Closed
AssetMark Inc
191
AssetMark Inc
California
– -$1.37M -4,332 Closed
Public Employees Retirement Association of Colorado
192
Public Employees Retirement Association of Colorado
Colorado
– -$1.34M -4,240 Closed
FC
193
FORA Capital
Florida
– -$1.31M -4,148 Closed
Qube Research & Technologies (QRT)
194
Qube Research & Technologies (QRT)
United Kingdom
– -$1.31M -4,128 Closed
VFA
195
Values First Advisors
Tennessee
– -$1.28M -4,039 Closed
NYLIM
196
New York Life Investment Management
New York
– -$1.28M -4,033 Closed
BMSSC
197
B. Metzler seel. Sohn & Co
Germany
– -$1.27M -4,014 Closed
CGIM
198
Capital Group Investment Management
Singapore
– -$1.2M -3,776 Closed
Pictet Asset Management
199
Pictet Asset Management
Switzerland
– -$1.18M -3,740 Closed
APF
200
Alaska Permanent Fund
Alaska
– -$1.16M -3,677 Closed
6 7
8
9 10

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.